# Gate Review: Heavy ULW Research 20260701-235345

## recommendation

APPROVE

## blockers

None.

## originalIntent

The user wanted Korean MECE research and organization of design and requirements for three Kakao AGENTIC PLAYER hackathon MCP concepts, with special emphasis on data pipelines.

## desiredOutcome

The shipped artifact should give Korean-first entrypoints and research deliverables for:

- `family-experience-mcp`
- `pharmacy-now-mcp`
- `parent-trust-mcp`

It should include shared data-pipeline architecture, per-concept source registries, normalized data requirements, confidence/freshness/failure policies, MVP cut lines, and explicit unresolved risks.

## userOutcomeReview

The blocker fixes are supported by the artifacts:

- Korean-first output contract is now met for the main synthesis, shared data-pipeline architecture, per-concept MECE research, and README entrypoints. Section headings are Korean-first except branch path titles, which are acceptable identifiers.
- Current-run QA evidence exists in `.omo/ulw-research/20260701-235345/QA_REVIEW.md`, and `.omo/ulw-research/20260701-235345/NOTEPAD.md` records the post-reject fix pass.
- `programming` criteria are N/A because the scoped review paths contain no `.py`, `.pyi`, `.rs`, `.ts`, `.tsx`, `.mts`, `.cts`, or `.go` files.
- `remove-ai-slops` production cleanup workflow is N/A because this is document-only work. Direct manual slop review found no new blocking slop: no fake live/current claim, no hard pharmacy open-now guarantee, no parent safety verdict, no broad crawler commitment, no implementation disguised as proof, and no unsupported API-key readiness claim.
- Branch README file lists now include `MECE_RESEARCH.md`, `DATA_PIPELINE.md`, `MCP_TOOLS.md`, `GOLDEN_PROMPTS.md`, `EXPERIMENTS.md`, `DEBATE.md`, and `REFINED_PROPOSAL.md` in all three concept folders.

The user-visible result matches the request: the documents now organize the three MCP concepts MECE-style in Korean and make the data-pipeline decisions explicit enough for the next implementation step.

## checkedArtifactPaths

- `.omo/ulw-research/20260701-235345/NOTEPAD.md`
- `.omo/ulw-research/20260701-235345/QA_REVIEW.md`
- `.omo/ulw-research/20260701-235345/SYNTHESIS.md`
- `.omo/ulw-research/20260701-235345/claim-ledger.md`
- `.omo/ulw-research/20260701-235345/wave-1-returns.md`
- `concept/DATA_PIPELINE_ARCHITECTURE.md`
- `concept/family-experience-mcp/MECE_RESEARCH.md`
- `concept/pharmacy-now-mcp/MECE_RESEARCH.md`
- `concept/parent-trust-mcp/MECE_RESEARCH.md`
- `concept/README.md`
- `concept/family-experience-mcp/README.md`
- `concept/pharmacy-now-mcp/README.md`
- `concept/parent-trust-mcp/README.md`

## directChecks

- Required review skills consulted:
  - `omo:remove-ai-slops`
  - `omo:programming`
- Artifact presence check:
  - all scoped paths were present.
- README list check:
  - all three branch folders contain the expected seven branch files plus `README.md`.
- Scoped code-file check:
  - no `.py`, `.pyi`, `.rs`, `.ts`, `.tsx`, `.mts`, `.cts`, or `.go` files found under `.omo/ulw-research/20260701-235345` or `concept`.
- Korean-first heading check:
  - main reviewed docs use Korean-first headings such as `결론`, `공통 데이터 파이프라인`, `제품 설계`, `소스 레지스트리`, `데이터 파이프라인 요구사항`, `MVP 절단선`, and `미해결`.
- Risk/slop grep:
  - risky phrases such as `open now`, `운영 중`, `영업 중`, `safe/dangerous`, `No recall`, and `안전 점수` appear in prohibition, boundary, or risk-context passages, not as product claims.

## exactEvidenceGaps

- No tracked `git diff` is available because the reviewed artifacts are currently untracked. This is not blocking for this re-review because the user supplied explicit review-scope paths and those artifacts were inspected directly.
- External source freshness was not re-browsed in this gate pass. This is not blocking because the user requested a blocker-fix re-review against the artifacts, and the deliverables mark unresolved/account/API-key/live-payload dependencies explicitly.

